Symbios Orthopédie SA
Nick Karnas has a diverse professional background, starting as a Thuisverpleegkundige at De zorgvriend in June 2013. Nick then transitioned to a Spoedverpleegkundige at AZ Monica from September 2011 to February 2017. Nick also worked as a Medical sales representative at MENARINI Group from February 2017 to June 2018. Nick continued their career as a Clinical Support Specialist at Zimmer Biomet EMEA from July 2018 to September 2023, before taking on their current role as a Sales representative at Symbios Orthopédie SA. Nick earned a Bachelor's degree in Verpleegkunde in 2011 and a Bachelor's degree in Spoed en intensieve zorgen in 2014 from Artesis Hogeschool Antwerpen.
This person is not in any offices
Symbios Orthopédie SA
Symbios is a Swiss medical technology company, and the leader in custom-made orthopaedic implants for hip and knee joint replacement. It was founded in 1989 by Jean Plé and two associates, including an orthopedic surgeon. Their vision was to design and manufacture custom-made implants that adapt perfectly to each patient’s individual anatomy. As there are as many different body shapes as there are patients, a custom-made implant is above all a unique implant for a unique patient, designed to better restore mobility and satisfaction. Since its creation and based today on 30 years of experience, Symbios has pioneered and constantly improved the technology of custom implant manufacturing, thus becoming the company with the greatest expertise in this field worldwide. In addition to providing products that are better adapted to patients, customization of implants enables a major breakthrough in today’s orthopedic supply model, allowing for a significant reduction in stocks and instruments for healthcare facilities. The cost of healthcare linked to changing demographics is a growing concern, and we believe that this is the ultimate way to maximize the efficiency of healthcare facilitiesand enable them to reduce operational costs in the future, while improving the quality of care.